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Enantioselective total synthesis of epoxyquinone natural
products ()-phyllostine, (+)-epoxydon, (+)-epiepoxydon and
()-panepophenanthrin: access to versatile chiral building
blocks through enzymatic kinetic resolution
Goverdhan Mehta* and Kabirul Islam
Department of Organic Chemistry, Indian Institute of Science, Bangalore 560 012, IndiaAbstract—A new enzyme mediated protocol to access versatile chiral building blocks for the synthesis of epoxyquinone natural
products is delineated. Total syntheses of ()-phyllostine, (+)-epoxydon, (+)-epiepoxydon and ()-panepophenanthrin have been
accomplished to demonstrate the efficacy of this approach.C
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3. (-)-Theobroxide
6. (+)-HarveynoneA range of polyketide derived natural products,
embodying a compact epoxyquinone derived motif 1,
as the core structure, have been encountered among di-
verse sources like bacteria, fungi, higher plants and mol-
lusks.1 Representative examples of such polyoxygenated
cyclohexanoids are (+)-epoformin 2a,1a (+)-epiepoformin
2b,1b ()-theobroxide 3,1c ()-phyllostine 4,1d(+)-epoxy-
don 5a,1e (+)-epiepoxydon 5b1f and (+)-harveynone 6.1g
These and related natural products have stimulated
much synthetic activity due to their structural and
stereochemical diversity and their wide ranging biologi-
cal activity, from phytotoxicity, anti-fungal, anti-
bacterial and anti-tumour to various kind of enzyme
inhibition.2
More recently, a complex natural product (+)-panepo-
phenanthrin 8,3 derived through a biosynthetic Diels–
Alder reaction from a monomeric epoxyquinone precur-
sor 7, has been isolated from the fermentation broth of
the mushroom strain Panus rudis Fr. IFO8994 and has
aroused considerable current interest among synthetic
chemists due to its unique activity in inhibiting the ubi-
quitin activating enzyme (E1), which is indispensable to
the ubiquitin–proteosome pathway (UPP).4
As a part of our ongoing interest in the synthesis of
epoxyquinone natural products,4c,5 we further highlight* Corresponding author. E-mail: gm@orgchem.iisc.ern.inhere the efficacy of the readily available Diels–Alder ad-
duct 96 of cyclopentadiene and p-benzoquinone and its
epoxide 10 as versatile building blocks for the synthesis
of natural products embodying the structural motif 1.
A notable feature of the efforts outlined here is the con-
venient and efficient enzyme mediated kinetic resolution
of a derivative of 10 to provide access to both the enan-
tiomeric forms of the core structure 1. One of these
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Scheme 2. Reagents and conditions: (a) Lipase PS-D (Amano), vinyl
acetate, rt, 28h. ()-13, 45%, (+)-14, 46%.
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7 (+)-8enantiomers has been elaborated to the natural products
()-phyllostine 4, (+)-epoxydon 5a and (+)-epiepoxy-
don 5b and also utilized for the total synthesis of ()-
panapophenanthrin 8, the antipode of the biologically
important natural product (+)-8. These endeavours to-
wards the total synthesis of epoxyquinone natural prod-
ucts constitute the theme of this letter.
Readily available tricyclic endo-adduct 9 can be conve-
niently transformed to 107 in high yield and further
exposure to formalin solution in the presence of catalytic
amounts of DBU under controlled conditions led stere-
oselectively to the a-hydroxymethylated product 11 in
excellent yield (Scheme 1). TBS-protection of the hydr-
oxyl group in 11 to yield 12 and sodium borohydride
reduction stereoselectively furnished the endo-alcohol
13 (Scheme 1).7 After some trial experimentation, it
was found that 13 was amenable to efficient enzymatic
kinetic resolution through transesterification.8 Thus,
exposure of (±)-13 to lipase PS-D in vinyl acetate sol-
vent and termination of the reaction at nearly 50%
transesterification led to the isolation of hydroxy com-
pound ()-13 (45% yield, 99% ee)8 and acetate (+)-
14 (46% yield, 99% ee)8 with high enantioselectivity
and in preparatively useful yields (Scheme 2).7,8 Both
()-13 and (+)-14 are serviceable for the synthesis ofO
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Scheme 1. Reagents and conditions: (a) 30% H2O2, 10% Na2CO3,
acetone, 0 C, 96%; (b) 0.1equiv DBU, 40% formalin, THF, 0 C, 95%;
(c) TBSCl, imid. DMAP, DMF, rt, 92%; (d) NaBH4, MeOH, 15 C,
81%.diverse natural products and herein we describe a few
syntheses emanating from (+)-14.
Enantiopure tricyclic acetate (+)-14 on thermal activa-
tion underwent facile retro-Diels–Alder reaction to elim-
inate cyclopentadiene and deliver epoxyquinone
derivative (+)-15 (Scheme 3).7 Acetate hydrolysis in
(+)-15 gave (+)-16 and further TBS deprotection fur-
nished the natural product (+)-epiepoxydon 5b ([a]D
+250, c 1.4, EtOH; lit.1f,2k [a]D (+)-256, c 0.8, EtOH)7
whose spectral data were found to be identical with
those reported in the literature.1f,2k
Hydroxy-enone (+)-16 was also suitable for the synthe-
sis of the natural product (+)-epoxydon 5a and this re-
quired stereochemical inversion of the secondary
hydroxyl group. Consequently, (+)-16 was directly sub-
jected to the Mitsunobu protocol9 to deliver the hydr-
oxyl inverted product (+)-17 after hydrolysis (Scheme
4).7 TBS-deprotection in (+)-17 led to (+)-epoxydon 5a
([a]D +98, c 1.0, EtOH; lit.1e [a]D +102, c 1.0, EtOH)
and its spectral characteristics were found to be identical
to those reported1e for the natural product (Scheme 4).7OAc
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Scheme 3. Reagents and conditions: (a) diphenyl ether, 240C, 5min,
93%; (b) LiOH, MeOH, 0 C, 75%; (c) HF–pyridine, THF, 0 C, 80%.
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Scheme 4. Reagents and conditions: (a) (i) PPh3, DIAD, PNBA, THF,
50C to rt; (ii) LiOH, MeOH, 0 C, 65% (two steps). (b) HF–
pyridine, THF, 0 C, 76%.
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Scheme 6. Reagents and conditions: (a) HF–pyridine, THF, 0 C, 92%;
(b) DIBAL-H, THF, 78C, 72%; (c) TEMPO, O2, CuCl, DMF, rt,
81%; (d) Ph3P@CHCOOMe, benzene, rt, 94%.
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lective synthesis of the natural product, (+)-epoxydon.10
For the synthesis of ()-phyllostine, the hydroxyl group
in (+)-16 was subjected to oxidation with PDC to give
()-18 and further TBS-deprotection led to the epoxy-
quinone natural product ()-4 ([a]D 108, c 1.61, EtOH;
lit.1d [a]D 105, c 1.0, EtOH), Scheme 5.7 The spectral
data for our synthetic ()-phyllostine were found to be
identical with those reported for the natural product.
Monocyclic acetate (+)-15 (Scheme 3) was considered as
a suitable starting point for accessing the precursor 7 for
a synthesis of ()-panepophenanthrin 8, the antipode of
the natural product.3 It has been shown by others4a,b
and us4c that 7 undergoes spontaneous dimerization
via a biomimetic Diels–Alder reaction to panepophe-
nanthrin 8. Thus, accessing 7 became our penultimate
objective. TBS deprotection in (+)-15 gave (+)-19 and
further DIBAL-H11 reduction of the carbonyl group
proceeded under chelation control to furnish diol (+)-
20 as a single diastereomer (Scheme 6).7 The primary
hydroxyl group in diol (+)-20 was chemoselectively
oxidized in the TEMPO–O2–CuCl
12 milieu to furnish
aldehyde (+)-21. Horner–Wittig olefination in the
hydroxyaldehyde 21 proceeded smoothly to render the
(E)-a,b-unsaturated ester (+)-22 in good yield (Scheme
6).7 At this stage, it was necessary to carry out a methyl
lithium addition to the ester carbonyl group of (+)-22 to
deliver the desired side chain present in 7. However, the
presence of the acetate group in (+)-22 made this
manoeuvre extremely messy and difficult to execute
and therefore a more circuitous approach at the expense
of a few additional steps was adopted. Acetate hydroly-
sis in (+)-22 was uneventful and led to the diol (+)-23 in
which one hydroxyl group was regioselectively protected
as its TBS-derivative (+)-24 (Scheme 7).7 Addition ofO
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Scheme 5. Reagents and conditions: (a) PDC, DCM, 0C, 89%; (b)
HF–pyridine, THF, 0 C, 72%.
OH7
Scheme 7. Reagents and conditions: (a) LiOH, MeOH, 0 C, 88%; (b)
TBSOTf, imid. DMAP, DMF, rt, 71%; (c) MeLi, THF, 0 C, 60%; (d)
MnO2, DCM, rt, 74%; (e) HF–pyridine, THF, 0 C, 94%; (f) neat, 30h,
82%.methyllithium to (+)-24 was now smooth and delivered
(+)-25. Oxidation of the allylic hydroxyl group in (+)-
25 furnished the enone (+)-267 and TBS deprotection
led to the monomeric precursor 7 of the natural product
panepophenanthrin (Scheme 7). When 7 was left neat
under ambient conditions (26 C) for 30h, it began
to solidify and was transformed into a single dimeric
product ()-8 through a stereospecific intermolecular
Diels–Alder reaction.13 The spectral data for ()-8 were
identical with that of the natural product but had a rota-
tion ([a]D 147, c 1.0, MeOH) opposite in sign to that of
the natural product (lit.3 [a]D +149.8, c 1.0, MeOH).7
Thus, the first synthesis of the antipode of the biologi-
cally potent natural product panepophenanthrin has
been achieved and its biological activity profile is being
evaluated.
In short, we have devised a simple enzyme mediated
strategy to access chiral building blocks for the synthesis
of a range of biologically active epoxyquinone natural
products from readily available starting materials. This
versatile approach has resulted in the short syntheses
of natural products ()-phyllostine, (+)-epoxydon, (+)-epi-
epoxydon and ()-panepophenanthrin.Acknowledgements
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